altavitaD3 25,000 IU soft capsules
*Company:
Consilient Health LtdStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 08 April 2025
File name
ie-mt-spc-25k.pdf
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to section 8 - Marketing authorisation number(s)
- Change to section 9 - Date of first authorisation/renewal of the authorisation
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 08 April 2025
File name
03_P1739_25k_160x240-28-03-2025.pdf
Reasons for updating
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 15 February 2024
File name
ie-leaflet-25k-clean-v027.pdf
Reasons for updating
- Change to section 6 - what the product looks like and pack contents
Updated on 15 February 2024
File name
ie-spc-25k-clean-v027.pdf
Reasons for updating
- Change to section 3 - Pharmaceutical form
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 30 November 2023
File name
ie-spc-25k-clean-MAH address change--.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 30 November 2023
File name
ie-spc-25k-clean-MAH address change--.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 01 September 2023
File name
ie-spc-25k-clean-MAH address change-.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 01 September 2023
File name
01_P1591_25k_v025.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
Updated on 01 December 2022
File name
ie-spc-25k-0026.pdf
Reasons for updating
- Change to section 6.3 - Shelf life
- Change to section 6.4 - Special precautions for storage
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 26 July 2022
File name
ie-spc-25000-approved 02.09.16.pdf
Reasons for updating
- Change to section 6.3 - Shelf life
- Change to section 6.4 - Special precautions for storage
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 26 July 2022
File name
05_P1027_25k_160x240-24-05-2022-appr. Jul22.pdf
Reasons for updating
- Change to section 5 - how to store or dispose
Updated on 08 February 2021
File name
ie-spc-25000-approved 02.09.16.pdf
Reasons for updating
- New individual SPC (was previously included in combined SPC)
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 29 November 2018
File name
ie-mockup-1-approved-19.09.18.pdf
Reasons for updating
- Change to section 6 - manufacturer
Updated on 17 March 2017
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 17 March 2017
Reasons for updating
- Change to section 4.1 - Therapeutic indications
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 15 February 2017
File name
PIL_17090_998.pdf
Reasons for updating
- New PIL for new product
Updated on 15 February 2017
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Consilient Health Ltd
Address:
Block 2A Richview Office Park, Clonskeagh, Dublin 14, IrelandMedical Information E-mail:
drugsafety@consilienthealth.comTelephone:
353 1 2057760Medical Information Facsimile:
+44 (0) 203 751 1889Medical Information Direct Line:
+44 (0) 203 751 1888